Currently accepting select investor inquiries — Learn more

Our People

The team behind HARMONY.

A physicist who invented new equations. An oncologist who publishes in Nature. A lawyer who co-founded a $3B public company. This is not a typical biotech founding team — and HARMONY is not a typical biotech platform.

Physics, medicine, and execution.

Chase McMichael

Chase K. McMichael

Founder · CEO · CSO

Physicist and discoverer of backbone dihedral perturbation analysis — the foundational physics that powers HARMONY. Developed the McMichael-Dicke Equation and PHASAL field theory. Architect of the ARC-X SUPER platform. Sole inventor of record on all method patents and 9 Composition of Matter families — driving the platform from first principles to filed IP without a co-inventor.

BS Physics & Chemistry 7 Provisional Patents 210+ Claims Filed 9 CoM Families
Lincoln Nadauld

Lincoln D. Nadauld, MD, PhD

Chief Medical Officer

Practicing precision oncologist at Intermountain Health. First and senior author in Nature Genetics and Nature — two of the most prestigious scientific journals in the world. Translates genomic variant data into clinical strategy. Senior and corresponding author on InfiniGraph's DDR validation manuscript. Leads clinical development and target selection.

MD, PhD Nature Genetics Author Precision Oncologist Intermountain Health
Michael Wiley

Michael Wiley, JD

General Counsel

Co-founder of Guardant Health, one of the defining liquid biopsy companies in oncology — now a publicly traded company with a market cap exceeding $3 billion. Deep expertise in life science IP strategy, licensing, and commercialization. Oversees InfiniGraph's IP fortress architecture and pharma partnership structure.

JD Guardant Health Co-Founder $3B+ Public Company Life Science IP Expert
"
A physicist who invented new equations. An oncologist who publishes in Nature. A lawyer who co-founded a $3 billion public company. This is not a typical biotech team.

InfiniGraph — 2026

We are building the team that changes drug discovery.

If you are a scientist, engineer, or operator who believes physics-first drug discovery is the future of medicine, we want to hear from you.

Get in touch